Follow
Peter C. Adamson
Peter C. Adamson
Children's Hospital of Philadelphia/UPenn
Verified email at email.chop.edu
Title
Cited by
Cited by
Year
Understanding and managing methotrexate nephrotoxicity
BC Widemann, PC Adamson
The oncologist 11 (6), 694-703, 2006
8662006
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
YP Mossé, MS Lim, SD Voss, K Wilner, K Ruffner, J Laliberte, D Rolland, ...
The lancet oncology 14 (6), 472-480, 2013
7842013
Declining childhood and adolescent cancer mortality
MA Smith, SF Altekruse, PC Adamson, GH Reaman, NL Seibel
Cancer 120 (16), 2497-2506, 2014
7252014
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy
TA Glauser, A Cnaan, S Shinnar, DG Hirtz, D Dlugos, D Masur, PO Clark, ...
New England Journal of Medicine 362 (9), 790-799, 2010
6992010
Pharmacokinetics and safety of intravenous voriconazole in children after single-or multiple-dose administration
TJ Walsh, MO Karlsson, T Driscoll, AG Arguedas, P Adamson, ...
Antimicrobial agents and chemotherapy 48 (6), 2166-2172, 2004
4072004
High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma: incidence, treatment, and outcome
BC Widemann, FM Balis, B Kempf‐Bielack, S Bielack, CB Pratt, S Ferrari, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
3862004
Targeting ALK with crizotinib in pediatric anaplastic large cell lymphoma and inflammatory myofibroblastic tumor: a Children’s Oncology Group Study
YP Mossé, SD Voss, MS Lim, D Rolland, CG Minard, E Fox, P Adamson, ...
Journal of Clinical Oncology 35 (28), 3215, 2017
3822017
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months
TA Glauser, A Cnaan, S Shinnar, DG Hirtz, D Dlugos, D Masur, PO Clark, ...
Epilepsia 54 (1), 141-155, 2013
2902013
Shortening the timeline of pediatric phase I trials: the rolling six design
JM Skolnik, JS Barrett, B Jayaraman, D Patel, PC Adamson
Journal of Clinical Oncology 26 (2), 190-195, 2008
2852008
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents
TJ Walsh, PC Adamson, NL Seibel, PM Flynn, MN Neely, C Schwartz, ...
Antimicrobial agents and chemotherapy 49 (11), 4536-4545, 2005
2852005
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study
JLG Bender, PC Adamson, JM Reid, L Xu, S Baruchel, Y Shaked, ...
Journal of clinical oncology 26 (3), 399-405, 2008
2712008
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study
EA Raetz, MS Cairo, MJ Borowitz, SM Blaney, MD Krailo, TA Leil, JM Reid, ...
Journal of Clinical Oncology 26 (22), 3756, 2008
2522008
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study
M Bond, ML Bernstein, A Pappo, KR Schultz, M Krailo, SM Blaney, ...
Pediatric blood & cancer 50 (2), 254-258, 2008
2392008
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group
S Malempati, B Weigel, AM Ingle, CH Ahern, JM Carroll, CT Roberts, ...
Journal of Clinical Oncology 30 (3), 256, 2012
2102012
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report
M Fouladi, JR Park, CF Stewart, RJ Gilbertson, P Schaiquevich, J Sun, ...
Journal of Clinical Oncology 28 (22), 3623, 2010
2002010
Rituximab for high-risk, mature B-cell non-Hodgkin’s lymphoma in children
V Minard-Colin, A Aupérin, M Pillon, GAA Burke, DA Barkauskas, ...
New England Journal of Medicine 382 (23), 2207-2219, 2020
1932020
A phase I clinical trial of the hu14. 18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's …
KL Osenga, JA Hank, MR Albertini, J Gan, AG Sternberg, J Eickhoff, ...
Clinical cancer research 12 (6), 1750-1759, 2006
1922006
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome
BC Widemann, FM Balis, AR Kim, M Boron, N Jayaprakash, A Shalabi, ...
Journal of clinical oncology 28 (25), 3979, 2010
1882010
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study
TM Horton, D Pati, SE Plon, PA Thompson, LR Bomgaars, PC Adamson, ...
Clinical cancer research 13 (5), 1516-1522, 2007
1742007
Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.
MA Smith, PC Adamson, FM Balis, J Feusner, L Aronson, RF Murphy, ...
Journal of clinical oncology 10 (11), 1666-1673, 1992
1711992
The system can't perform the operation now. Try again later.
Articles 1–20